Bioregulator theory and mechanism Khavinson's bioregulator concept: Each organ produces specific regulatory peptides These peptides maintain tissue homeostasis With aging, peptide production declines Supplementing organ-specific peptides restores function Gene regulation is key mechanism How Cartalax works (theory): Enters cartilage cells (chondrocytes) Binds to specific DNA sequences Upregulates cartilage-protective genes Downregulates degradative genes Optimizes cartilage matrix production Gene expression changes: Upregulated (increased): Collagen Type II: Main cartilage structural protein Proteoglycans: Water-holding molecules Aggrecan: Cartilage compressive strength TGF-: Growth factors for cartilage Chondrocyte proliferation genes Downregulated (decreased): Matrix Metalloproteinases (MMPs): Cartilage-degrading enzymes Inflammatory cytokines: IL-1, TNF- Apoptosis genes: Prevents cartilage cell death Oxidative stress markers Mechanism comparison: Why bioregulation different: Works at DNA/gene level (root cause) Tissue-specific (only cartilage affected) Long-lasting effects (genes stay regulated) Cyclic dosing sufficient (vs continuous) Preventive and restorative Compare to other mechanisms and joint peptides
This suggests that the ongoing follicular development during late pregnancy may be affected due to subclinical pregnancy toxemia
IMPROVED CASE DESIGN The charger's sleek case fits perfectly on your workbench and in your pit or field bag
About this article Cite this article Jeyaraman, M., Jeyaraman, N., Sridhar, A.S
The results of a trial of semaglutide in obese patients with HFpEF showed a significant amelioration of symptoms and improvements in motor function and weight loss compared with patients treated with a placebo.470 In this study, researchers randomized 529 patients with heart failure with a preserved ejection fraction and body mass index (weight in kilograms in the square of the height in meters) 30 to receive once-weekly injections of semaglutide (2.4 mg) or placebo for 52 weeks
